by SIOBHAN COSTIGAN
On the evening of 13 September 2007, a gifted young Philosophy student who had just completed her PhD got up suddenly from the computer she was working on in the study of her parent’s home in the leafy Sydney suburb of Lavender Bay. Barefoot and wearing only her pyjamas (which she had changed into only minutes earlier in preparation for bed), she left the house and walked out into the cold, dark night. Ten minutes later, with a blank and vacant expression on her face, she climbed onto a ledge and plunged twenty metres to her death.
That girl was my youngest sister, Mairead, who died while in an apparent sleepwalking state, which investigating detectives attributed to her intake of the controversial sleep medications Stilnox (zolpidem) and Imovane (zopiclone). Mairead had no history of depression or mental illness, and no history of drug use or abuse.
She had been taking Stilnox and Imovane exactly as directed by her GP, though she had been prescribed the drugs over a longer period than is recommended. The postmortem toxicology report showed that she had taken only one tablet very shortly before her death, and there were no other drugs or alcohol found in her system.
This class of drugs (known as ‘z drugs’) have been the subject of intense media coverage in Australia in recent times, and both zolpidem and zopiclone have been associated with a range of neurological and psychiatric effects, including sleep walking, sleep driving, sleep cooking, sleep eating and sleep sex. Most recently, they’ve been back in the media after the Olympic swimming champion Grant Hackett revealed that he had developed a strong addiction to Stilnox, which he used regularly during his career, and which he now describes as “evil”.